English
|
正體中文
|
简体中文
|
Items with full text/Total items : 12340/13424 (92%)
Visitors : 2037425 Online Users : 419
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by
NTU Library IR team.
Scope
All of NHRI
National Institute of Cancer Research
Yung-Yeh Su
--Periodical Articles
--Conference Papers/Meeting Abstract
Tips:
please add "double quotation mark" for query phrases to get precise results
please goto advance search for comprehansive author search
Adv. Search
Home
‧
Login
‧
Upload
‧
Help
‧
About
‧
Administer
NHRI
>
National Institute of Cancer Research
>
Yung-Yeh Su
>
Browse By Title
Browse By Authors
Browse By Date
Browse By Data Type
Community Detail
Introduction:
NA
Loading...
Collection
Periodical Articles
[
33
/33]
Conference Papers/Meeting Abstract
[
8
/8]
Siblings
Winston C.Y. Yu
[
19
/19]
Ko-Jiunn Liu
[
87
/107]
Tsang-Wu Liu
[
120
/126]
Jieh-Yuan Liou(2003-2010)
[
3
/3]
Her-Shyong Shiah(1996-2012)
[
26
/31]
Shine-Gwo Shiah
[
51
/54]
Nai-Jung Chiang
[
85
/97]
Hui-Ju Mandy Ch'ang
[
40
/45]
Jang-Yang Chang
[
234
/254]
Kwang-Yu Chang
[
70
/80]
I-Shou Chang
[
104
/107]
Wun-Shaing Wayne Chang
[
52
/54]
Jeffrey Shu-Ming
[
89
/91]
Jacqueline Whang-Peng(1996-2007)
[
120
/126]
Neng-Yao Shih
[
37
/47]
Chia-Huei Lee
[
29
/29]
Alan Yueh-Luen Lee
[
49
/55]
Su-Fang Lin
[
32
/32]
Yi-Hsin Yang
[
44
/45]
Shih-Sheng Jiang
[
90
/92]
Che-Hung Shen
[
14
/16]
Wen-Chun Hung
[
88
/92]
Shuang-En Chuang
[
82
/91]
Kelvin Kun-Chih Tsai
[
32
/35]
Hui-Jen Tsai
[
67
/85]
Jen-Liang Su
[
24
/25]
Ching-Chuan Kuo
[
71
/76]
Shang-Hung Chen
[
46
/49]
Jen-Yang Chen
[
72
/72]
Li-Tzong Chen
[
447
/518]
Mei-Shya Chen(2002-2009)
[
1
/1]
Shih-Cheng Chen
[
2
/2]
Ya-Wen Chen
[
39
/40]
Tze-Sing Huang
[
56
/57]
Dau-Yang Huang
[
27
/27]
Chou-Chik George Ting(2000-2004)
[
5
/5]
Others
[
470
/478]
Ming Jacqueline Liu(1996-2007)
[
60
/62]
Mei-Ying Liu(2004-2006)
[
2
/2]
Cheng-Wen Wu(1996-2008)
[
53
/56]
Szu-Wen Tseng(1997-2007)
[
4
/4]
Kuan-Te Li(1997-2004)
[
4
/6]
Ching-Tai Lin(1999-2007)
[
5
/5]
Wen-Kuang Yang(1996-1999)
[
21
/21]
Chuan-Cheng Wang(1996-2003)
[
4
/4]
Shin-Hun P. Juang(1997-2004)
[
11
/11]
Tzung-Huang Jan(2000-2008)
[
2
/2]
Gi-Ming Lai(2004-2008)
[
41
/47]
Li-Jung Juan(2000-2006)
[
6
/7]
Jim-Ray Chen(2003-2007)
[
6
/6]
Yen-Ying Ma(1997-1999)
[
1
/1]
Chi-Ying F. Huang(2005-2007)
[
9
/10]
Community Statistics
Item counts issued in 3 years:19(46.34%)
Items With Fulltext:41(100.00%)
Download counts of the item
Download times greater than 0:41(100.00%)
Download times greater than 100:33(80.49%)
Total Bitstream Download Counts:7486(0.13%)
Last Update: 2025-03-02 07:46
Top Upload
Loading...
Top Download
Loading...
Recent Submissions
Intercellular TIMP-1-CD63 signaling...
Pathological response following neo...
Clinical outcomes and histologic fi...
Cytoplasmic lipid droplets predict ...
A phase 1 study of biweekly nab-pac...
Outcomes of post-immunotherapy dura...
Impact of previous S-1 treatment on...
Neuron-derived neurotensin promotes...
Germline mutations of homologous re...
Systemic treatments in pancreatic c...
Jump to a point in the index:
(Choose year)
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
1993
1992
1991
1990
1985
1980
1975
1970
1960
1950
(Choose month)
January
February
March
April
May
June
July
August
September
October
November
December
Or type in a year:
Ordering With Most Recent First
Show Oldest First
Showing items 1-25 of 41. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
Date
Title
Relation
2025-01-18
Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells
Molecular Cancer. 2025 Jan 18;24:Article number 25.
2024-12
Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab
Journal of Clinical Oncology. 2024 Dec;42(34):4060-4070.
2024-11
Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes
American Journal of Surgical Pathology. 2024 Nov 1;48(11):1425-1438.
2024-11
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis
Lancet. Oncology. 2024 Nov;25(11):1465-1475.
2024-10
A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study
Oncologist. 2024 Oct 3;29(10):e1396-e1405.
2024-06
Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation
Biomedical Journal. 2024 Jun;47(3):Article number 100696.
2024-05
Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer
Pancreatology. 2024 May;24(3):600-607.
2024-02-15
Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway
American Journal of Cancer Research. 2024 Feb 15;14(2):448-466.
2024-02-13
Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan
Journal of Biomedical Science. 2024 Feb 13;31:Article number 21.
2024-02-01
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression
Liver Cancer. 2024 Feb 01;Article in Press.
2023-11
Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome
Annals of Oncology. 2023 Nov;34(Suppl. 3):S1390.
2023-11
Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis
Annals of Oncology. 2023 Nov;34(Suppl. 4):S1536-S1537.
2023-09-01
The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study
International Journal of Surgery. 2023 Sep 1;109(9):2614-2623.
2023-08-15
Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination
American Journal of Cancer Research. 2023 Aug 15;13(8):3417-3432.
2023-06
Investigation into the content of red material in EUS-guided pancreatic cancer biopsies
Gastrointestinal Endoscopy. 2023 Jun;97(6):1083-1091.e1.
2023-06
Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS)
Journal of Clinical Oncology. 2023 Jun;41(16 Suppl.):Meeting Abstract 11551.
2023-03
Tissue quality comparison between heparinized wet suction and dry suction in endoscopic ultrasound-fine needle biopsy of solid pancreatic masses: A randomized crossover study
Gut and Liver. 2023 Mar 15;17(2):318-327.
2023-02-05
Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer
Cancers. 2023 Feb 5;15(4):Article number 1008.
2023-02
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan
ESMO Open. 2023 Feb;8(1):Article number 100746.
2022-11-15
The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma
American Journal of Cancer Research. 2022 Nov 15;12(11):5062-5073.
2022-10
Impaired chromatin remodeling predicts better survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract Cancer: A phase II T1219 study
Clinical Cancer Research. 2022 Oct 3;28(19):4248-4257.
2022-10
Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression
Hepatology. 2022 Oct;76(Suppl.1):S1411-S1412.
2022-09-21
Clustering of chromatin remodeling enzymes predicts prognosis and clinical benefit of therapeutic strategy in pancreatic cancer
International Journal of Medical Sciences. 2022 Sep 21;19(10):1615-1627.
2022-07
Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience
Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-07
Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
Annals of Oncology. 2022 Jul;33(Suppl. 6):S484.
Showing items 1-25 of 41. (2 Page(s) Totally)
1
2
>
>>
View [
10
|
25
|
50
] records per page
DSpace Software
Copyright © 2002-2004
MIT
&
Hewlett-Packard
/
Enhanced by
NTU Library IR team
Copyright ©
-
Feedback